Puma Biotechnology reports Q4 adjusted EPS 43c, two estimates 14c
PremiumThe FlyPuma Biotechnology reports Q4 adjusted EPS 43c, two estimates 14c
1M ago
Puma Biotechnology sees Q1 product revenue $41M-$43M
Premium
The Fly
Puma Biotechnology sees Q1 product revenue $41M-$43M
1M ago
Puma Biotechnology sees FY25 product revenue $192M-$198M
Premium
The Fly
Puma Biotechnology sees FY25 product revenue $192M-$198M
1M ago
H.C. Wainwright says NCCN addition could positively impact Puma’s Nerlynx sales
PremiumThe FlyH.C. Wainwright says NCCN addition could positively impact Puma’s Nerlynx sales
3M ago
Puma Biotechnology neratinib included in NCCN guidelines
Premium
The Fly
Puma Biotechnology neratinib included in NCCN guidelines
3M ago
Puma Biotechnology initiates ALISertib in CAncer trial
Premium
The Fly
Puma Biotechnology initiates ALISertib in CAncer trial
5M ago
Puma Biotechnology sees Q3 net product revenue $50M-$53M
PremiumThe FlyPuma Biotechnology sees Q3 net product revenue $50M-$53M
8M ago
Puma Biotechnology reports Q2 EPS (9c), consensus (13c)
Premium
The Fly
Puma Biotechnology reports Q2 EPS (9c), consensus (13c)
8M ago
PBYI Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PBYI Upcoming Earnings Report: What to Expect?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100